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Abstract
Inheritance patterns in mice suggested that resistance to flavivirus-induced disease was conferred by a single autosomal dominant allele (Flvr). A
positional cloning strategy followed by comparison of Flv interval gene sequences from congenic resistant C3H.PRI-Flvr and susceptible C3H/He
mouse strains identified the 2′–5′-oligoadenylate synthetase 1b (Oas1b) gene asFlv.However, since these mouse strains differ by a 31 cM region, the
possible involvement of differences in other linked genes in the resistant phenotype could not be absolutely ruled out. Knock-in of the Oas1b
resistance allele into a susceptible mouse strain producedmicewith the flavivirus resistance phenotype, confirming that this phenotype is mediated by
a single gene.
© 2007 Elsevier Inc. All rights reserved.Keywords: Flavivirus resistance gene; Flv; Oas1b knock-in mouse; Oas1br alleleIntroduction
Inheritance patterns of resistance to flavivirus-induced
disease in mice suggested that this phenotype was controlled
by a single autosomal dominant allele (Flvr). This resistance is
flavivirus specific. Studies with the congenic resistant C3H.PRI-
Flvr and susceptible C3H/He mouse strains showed that
although resistant mice support the replication of flaviviruses,
virus titers in their tissues are significantly lower and the spread
of infection is slower than in susceptible mice (Brinton and
Perelygin, 2003). The Flv locus was mapped on mouse
chromosome 5 by linkage analysis, first with gene and then
with microsatellite markers (Jerrells and Osterman, 1981;
Urosevic et al., 1997). A positional cloning strategy was used
to identify the Flv gene as the 2′–5′-oligoadenylate synthetase
1b gene (Oas1b) by correlation between genotype and
phenotype in 10 mouse strains (Perelygin et al., 2002). Mouse
strains that are susceptible to flaviviruses have a C-to-T
transition in exon 4 of Oas1b that introduces a premature stop⁎ Corresponding author. Fax: +1 404 413 5301.
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doi:10.1016/j.virol.2007.08.017codon.Mashimo et al. (2002) confirmed the identification of this
gene. Oas1b belongs to the 2′–5′-oligoadenylate synthetase
family. These enzymes are activated by dsRNA to synthesize
2′–5′ oligo A. These oligomers activate RNase L, which in turn
degrades single-stranded viral and cell RNAs (Samuel, 2001).
However, the flavivirus resistance phenotype is not mediated by
RNase L activity (Scherbik et al., 2006) and Oas1b is not a
functional synthetase (Elbahesh et al., unpublished data). The
mechanism by which Oas1br provides resistance to flavivirus-
induced disease is not yet known. The congenic resistant C3H.
PRI-Flvr and susceptible C3H/He mouse strains differ by a
region of about 31 cM (about 64 Mb of DNA) (Urosevic et al.,
1999) that contains more than 700 genes. Another flavivirus
resistant–susceptible congenic pair subsequently generated
differed by a 0.4 cM interval containing 13 genes (Mashimo et
al., 2002). Because a possible contribution of variations in
another gene to the resistance phenotype could not be
completely ruled out, knock-in of the Oas1b resistance allele
into a susceptible mouse strain was done to create a pair of
mouse strains that differs at a single gene. The knock-in mice
were resistant to flavivirus-induced disease confirming that this
resistance phenotype is mediated by a single gene.
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To demonstrate the function of a gene, a knock-out strategy is
typically used. However, all of the available mouse embryonic
stem (ES) cell lines were derived from mouse strains with a
flavivirus susceptible phenotype and have an Oas1b allele that
encodes a C-terminally truncated protein. Therefore, a knock-in
strategy had to be used to determine whether replacement of a
single gene could confer the flavivirus resistance phenotype. A
genomic clone containing the whole Oas1b gene was obtained
from a cosmid library made from resistant C3H.PRI-Flvr DNA
(Scherbik et al., unpublished data). Several attempts to replace
the genomic Oas1b locus in genomes of susceptible mice with
the resistant C3H.PRI-Flvr Oas1b allele were unsuccessful. As
an alternative strategy, the premature stop codon of a susceptible
allele was changed to the coding triplet of the resistance allele.
Because the sequence following this stop codon would be
translated when the premature stop codon was removed, it was
also necessary to determine whether there were non-synon-
ymous substitutions in this region between resistant andFig. 1. Alignment of Oas1b protein sequences from flavivirus resistant (C3H.PRI-Flv
mouse strains. Only amino acid residues that differ from the C3H.PRI-Flvr sequence a
susceptible strain sequences are shown in bold. Residues for which codons were chsusceptible strains. The sequences of the 129SvJ/RW4 Oas1b
exons were amplified by PCR from the 12723 BAC clone
(Incyte Genomics) and sequenced. The deduced Oas1b amino
acid sequences from 3 flavivirus resistant, C3H.PRI-Flvr
(GenBank accession no. F328926), BRVR (GenBank accession
no. F418005) and MBT/Pas (GenBank accession no.
AF466823), and 3 susceptible mouse strains, C3H/He (Gen-
Bank accession no. AF418004), C57BL/6J (GenBank accession
no. NR_003507) and 129/SvJ/RW4, were compared using the
MegAlign program of the DNAStar software package (Fig. 1).
The position of translation termination in susceptible strain
sequences is indicated by an asterisk. The alignment revealed 4
amino acid substitutions (Q190R, Q266R, T299A and S336P)
that are conserved between all of the susceptible and resistant
strain sequences.
Because a premature stop codon is located in the Oas1b exon
4 in susceptible genomes, a targeting strategy was developed to
replace the 3′ half of the Oas1b gene in the genomic DNA of
129/SvJ ES cells (Fig. 2A) with DNA that corresponds to the
resistance allele of this gene. To construct the targeting vector,r, BRVR and MBT/Pas) and susceptible (C3H/He, C57BL/6J and 129/SvJ/RW4)
re shown. Amino acid residues that were conserved in resistant strains but not in
anged in the targeting construct are underlined.
Fig. 2. Targeted insertion of Oas1br. (A) Diagram of the 3′ portion of a susceptible mouse Oas1b gene. The positions of the BglII restriction sites that were used for
Southern blot analysis of homologous recombination events are indicated. (B) Diagram of the targeting vector which contained the Oas1b exon 4 and exon 5 regions
that were mutated at four positions, the left and right Oas1b homology arms (crossed dotted lines indicate regions of expected crossover), the loxP sites (inverted gray
triangles) and the inverted neo gene. (C) Diagram of the ES Oas1br after knock-in. The positions of the restriction sites are indicated. The location of the probe used for
Southern blot analysis is indicated by a filled square. (D) Southern blot analysis of knock-in and 129 ES cell DNA. KI-Oas1br knock-in. WT-129/SvJ/RW4. (E)
Diagram of the knock-in Oas1br genomic fragment in mice after removal of the neo cassette by Cre recombinase. The diagrams shown are not to scale.
234 Rapid Communicationtwo fragments from the Oas1b gene were generated from the
12,723 BAC clone selected from the 129/SvJ genomic library as
described in Materials and methods. The ∼4.2 kb KpnI/BamHI
fragment contained the left targeting arm, which consisted of the
intron between exons 3 and 4, and exon 4 (Fig. 2B). Subs-
titutions were made in this fragment by site-directed mutagen-
esis in exon 4 to change the premature stop codon TGA to CGA
(R) and also to change the CAA triplet encoding a Q amino acid
residue at position 266 to a CGA triplet encoding R (Fig. 2B).
The ∼2.7 kb BamHI/BamHI fragment contained the region
from exon 5 through exon 6 and a right targeting arm, which
consisted of the 3′ UTR of the Oas1b gene. Substitutions were
made in this fragment to change the ACT triplet encoding T at
position 299 to the GCT triplet encoding A and to change the
TCA triplet encoding S at position 336 to the CCA triplet
encoding P. The two mutated fragments were then cloned into
the targeting vector so that a selection marker, the neomycin
(neo) gene, was located in the intron between exons 4 and 5 in
opposite orientation to the Oas1b gene (Fig. 2B).
129/SvJ/RW4 ES cells were electroporated with the
linearized targeting construct and then cell clones were selected
for neo resistance and ganciclovir sensitivity. The presence of
the neo gene in the genomic DNA of each of 393 cell clones was
first confirmed by PCR using neo specific primers. To confirm
the occurrence of homologous recombination, positive ES cell
clones were next screened by Southern hybridization of BglII
digested genomic DNA using a probe located on the left side
outside of the targeted region (Fig. 2C). Correct targeting was
identified by detection of both an 8.1 kb fragment and the wild-
type 6.8 kb fragment (Fig. 2D). Four clones were shown to bepositive for a homologous recombination event (1.02%
frequency rate). This frequency is lower than typically observed
and is likely caused by off-targeting due to the presence of 8
closely spaced homologous Oas1 genes in mouse chromosome
5 (Eskildsen et al., 2002; Perelygin et al., 2002). The neo
cassette was removed in the ES cells using Cre recombinase
(Fig. 2E). Two of the “neo-less” clones were separately
microinjected into C57BL/6J blastocysts which were then
transplanted into pseudo-pregnant B6CBAF1/J females.
Chimeric males were mated with wild type C57BL/6J
females and two of the 8 chimeric founder mice demonstrated
germline transmission of the Oas1br knock-in allele. An inter-
cross mating was then performed between two F1 heterozygous
mice. The results of TaqMan 5′ allelic discrimination assay
(described in Materials and methods) of tail-snip DNA from all
F1, intercross and backcross offspring confirmed production of
the first generation of homozygous Oas1br knock-in mice.
The susceptibility of the Oas1br knock-in mice to flavivirus-
induced disease was analyzed after intracerebral inoculation of
undiluted 17D yellow fever virus vaccine (17D-YFV). Two
homozygous and 16 heterozygous Oas1br knock-in mice and 8
wild type C57BL/6J mice were injected. All of the C57BL/6J
mice developed hindlimb paralysis on day 8 or 9 after ino-
culation and were sacrificed prior to extreme morbidity (Fig.
3A). In contrast, none of the heterozygous or homozygous
Oas1br knock-in mice showed any signs of disease up to 24
days after inoculation. For comparison, results obtained after
intracerebral inoculation of congenic resistant C3H.PRI-Flvr
and susceptible C3H/He mice with the same dose of 17D-YFV
are shown (Fig. 3B). All of the susceptible mice developed
Fig. 3. Flavivirus challenge of Oas1br knock-in mice. (A) Survival curves of adult (6 week old) C57BL/6J mice (n=8), heterozygous Oas1br knock-in (n=16) and
homozygous Oas1br knock-in (n=2) mice. BL/6-C57BL/6J; KI-Oas1br knock-in. (B) Survival curves of adult (3 to 4 month old) C3H.PRI-Flvr (n=34) and C3H/He
(n=38) mice. All mice were inoculated intracerebrally with 0.02 ml of undiluted 17D-YFV vaccine.
235Rapid Communicationparalysis and morbidity between days 8 and 14, while none of
the C3H.PRI-Flvr mice showed any signs of disease.
Discussion
A flavivirus resistant phenotype was successfully generated
in a susceptible mouse strain by replacing the 3′ portion of the
susceptible Oas1b sequence in 129/SvJ/RW4 ES cells by
homologous recombination with a 129/SvJ/RW4 DNA
sequence containing four substitutions characteristic of the
Oas1b resistance allele. The most important change was
replacement of the premature TGA stop codon in exon 4.
Alignment of Oas1b protein sequences revealed differences at
positions 65, 190, 266, 299, 336, 347 and 350 between the
majority of the susceptible and resistant mouse strains. Since
only two of the three resistant strain Oas1b sequences had the
changes at positions 65, 347 and 350, these amino acid
substitutions were not considered to be critical for the
phenotype. The Q266R, T299A and S336P substitutions were
made to generate the amino acid sequence that was conserved in
flavivirus-resistant mouse strains. The codon for the amino acid
at position 190 was located in exon 3 which was outside the
targeted region and this codon was not changed. This change
was shown not to be required for the resistance phenotype of the
knock-in mice.
Attempts to knock-in the entire Oas1b resistant allele were
not successful. A ∼35 kb targeting vector, that consisted of a
13,943 bp Oas1br gene fragment (GenBank accession no.
AF481734; Scherbik et al., unpublished data) selected from a
C3H.PRI-Flvr cosmid genomic library, left (∼10 kb) and right
(∼7 kb) flanking arms selected from the 129/SvJ/RW4 BAC
library and the neo gene, was electroporated into 129/CJ7 ES
cells. Three out of 480 electroporated ES clones were positive
for homologous recombination. When these clones were
injected into blastocysts and then implanted into pseudopreg-
nant females, all three clones gave a dominant lethal phenotype.
Of the 5 chimeric pups that survived, the males did not produce
sperm and the females could not nurse.
Although the lengths of the flanking arms used were typical
for a large targeting construct, the close spacing of the 8adjacent Oas1 gene copies in the mouse genome made specific
homologous targeting very difficult. Possible problems with
this strategy were that the left arm contained the 5′ end of the
oppositely oriented Oas1c gene and homologous recombination
could have affected the function of this gene. It is not known
whether the Oas1c gene is involved in embryogenesis as has
been reported for Oas1d (Yan et al., 2005). The flanking arms
and the ES cells used were derived from two different 129
substrains and the right arm in the targeting construct contained
a retroelement (open reading frame gag) that was not present in
the ES cell genomic DNA. The heterozygosity of this
retroelement could have misregulated genes involved in early
embryogenesis as suggested in a previous study (Peaston et al.,
2004). To overcome these problems, the ES cells were changed
from 129/CJ7 to 129/SvJ/RW4 so that the flanking arm
sequences were identical in the construct and ES cells. Also,
an additional targeting vector was made in which the lengths of
the left and right arms were each shortened by about 3 kb.
Although positive ES clones were obtained after electroporation
of this vector and chimeric mice were subsequently generated,
germline transmission was not obtained with any of these
chimeras. Comparison of the Oas1b genomic sequences of
C3H.PRI-Flvr and 129/SvJ mice showed that the intron lengths
varied significantly between these two strains. These differ-
ences would be expected to decrease the efficiency of
homologous recombination and destabilize the targeted locus
in the ES cell genomic DNA.
The results of the virus challenge in the KI mice generated
indicated that the full length Oas1b protein is critical for
conferring the flavivirus resistance phenotype. The mechanism
by which the Oas1br mediates the flavivirus resistance
phenotype is not currently known. The Oas1b knock-in mice
represent a unique resource for further study of this mechanism.
Materials and methods
Construction of the Oas1br targeting vector
A 129/SvJ mouse ES RW4 cell BAC library (Incyte
Genomics) was screened with a probe specific for the 3′ UTR
236 Rapid Communicationof the Oas1b gene to obtain the BAC clone 12,723 containing
the complete genomic sequence of this gene. A subcloning
strategy was designed based on the Oas1b genomic sequence of
the C57BL/6 mouse strain (GenBank accession no AC015535).
The BAC DNAwas digested separately with BamHI or BamHI
and KpnI. The digestion products were separated on a 1%
agarose gel and two fragments from the 3′ half of the Oas1b
gene, KpnI–BamH1 (4165 bp) and BamHI–BamHI (2728 bp)
(Fig. 2B), were size selected and subcloned into the pCRScript
vector (Stratagene). Two substitutions were made in each
fragment by site-directed mutagenesis using a QuickChange
site-directed mutagenesis kit (Stratagene) according to the
manufacturer's protocol to generate a sequence characteristic of
the resistance allele. The mutated fragments were subsequently
cloned into a OSdupdel targeting vector (a gift from R.
Thresher, University of North Carolina at Chapel Hill). This
vector contains a 1.3 kb neo gene cassette (MC1neo) flanked by
two loxP sites, multiple cloning sites and the herpes simplex
virus thymidine kinase gene (TK). The neo and TK genes are in
the opposite orientation in this vector. Sequencing of the
targeting construct confirmed the correct sequence of both of
the subcloned Oas1b mutated fragments. Exponentially grow-
ing 129/SvJ/RW4 ES cells (Xenogen) were electroporated
(0.24 kV, 500 μF; Bio-Rad Gene Pulser) with linearized
targeting construct DNA and selected in a medium containing
250 μg/ml geneticin (G418) (Invitrogen) and 2 μM ganciclovir
(Sigma). Resistant clones were picked after 7 days and cell lines
were established. The floxed neo gene was removed from
correctly targeted ES cells by electroporating them with Cre
recombinase and isolating neos colonies prior to microinjection
of blastocysts.
Homologous recombination screening
Homologous recombination in ES cell clones was detected
by Southern blot analysis. ES cell DNAwas isolated according
to the methods of Laird et al. (1991). DNA (15 μg) was
digested with BglII, resolved on 1% agarose gels, transferred
to a Hybond-XL membrane (Amersham Biosciences) and
probed. The probe (0.528 kb) was generated by PCR from 129
BAC DNA using the following primers, 5′-ctgcgtattcatggt-
caagtagc-3′ and 5′-ctttgagtgtcctttgatctctg-3′. This probe
detected sequence located beyond the region of left arm
recombination (Fig. 2C). The hybridization fragments were
expected to be 6780 bp for parental DNA and 8060 bp for
knock-in DNA if the insertion of the neo gene occurred in the
correct position.
Mouse strains
All procedures done in mice were carried out in accordance
with protocols approved by the Wadsworth Center IACUC.
C57BL/6J mice were used for blastocyst harvest. Blastocysts
were microinjected with ES cells and then transferred to
pseudopregnant B6CBAF1/J female mice. For germline
transmission of the Oas1b, knock-in male chimeras were bred
with female C57BL/6J mice.Genotyping mice for the Oas1b knock-in allele
Tail-snip DNA was isolated with PUREGENE DNA puri-
fication kits (Gentra) and genotyping was done by the Wads-
worth Center Genotyping Core. Briefly, the mutation in Oas1b
exon 4 (NCBI refSNP ID: 32176593) that created a premature
stop codon was genotyped using an ABI TaqMan 5′ allelic
discrimination assay. The Assay-by-Design method was used to
design the following primers; forward (5′-gggagtatgggagtcgag-
taactaa-3′), reverse (5′-ctgtttgtacttggtgaccagttc-3′), VIC-labeled
probe (5′-acggttcggaagcc-3′) and FAM-labeled probe (5′-
cggttcagaagcc-3′). The assay was carried out in a volume of
5 μl. The final concentrations of the reagents were as follows:
900 nM of each primer, 200 nM of each labeled probe, 4 ng total
genomic DNA and a 1X final concentration of TaqMan
UniversalMasterMix (NoUNG). The thermocycling conditions
usedwere: 10min at 95 °C, followed by 40 cycles of 95 °C for 15
s, 60 °C for 1 min. End point fluorescence was detected using the
ABI 7900HT sequence detection system. Genotypes were
autocalled using the default settings found in the Sequence
Detection Software version 2.2.2 (Applied Biosystems). A
positive control for each genotype and four negative control
samples were used to ensure accurate genotype scoring.
Virus challenge
Adult mice anesthetized by inhalation of isofluorane
were injected with 0.02 ml of undiluted 17D yellow fever
virus vaccine (Connaught) by the intracerebral route using
a tuberculin syringe with a needle guard. Mice that deve-
loped hindlimb paralysis were sacrificed prior to extreme
morbidity.
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